EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Intramuscular but not nebulized administration of a mRNA vaccine against Rhodococcus equi stimulated humoral immune responses in neonatal foals

Rebecca M Legere iD, Cristina Poveda, Jeannine A Ott, Jocelyne M Bray, Emma G Villafone, Bibiana Petri da Silveira, Susanne K Kahn, Cameron L Martin, Chiara Mancino, Francesca Taraballi, Michael F Criscitiello, Luc Berghman und 3 weitere

American Journal of Veterinary Research · 2024

DOI: 10.2460/ajvr.23.09.0208 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Veterinary Research, 2024. Verfasst von Rebecca M Legere und 14 weiteren Autor:innen. Beteiligte Einrichtung: Equine Infectious Disease Laboratory, Department of Large Animal Clinical Sciences, School of Veterinary Medicine & Biomedical Sciences, Texas A&M Un…. Hauptthemen laut MEDLINE: Rhodococcus equi, Actinomycetales Infections, Horse Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVE Design and evaluate immune responses of neonatal foals to a mRNA vaccine expressing the virulence-associated protein A (VapA) of Rhodococcus equi . ANIMALS Cultured primary equine respiratory tract cells; Serum, bronchoalveolar lavage fluid (BALF), and peripheral blood mononuclear cells (PBMCs) from 30 healthy Quarter Horse foals. METHODS VapA expression was evaluated by western immunoblot in cultured equine bronchial cells transfected with 4 mRNA constructs encoding VapA. The mRNA construct with greatest expression was used to immunize foals at ages 2 and 21 days in 5 groups: (1) 300 μg nebulized mRNA (n = 6); (2) 600 μg nebulized mRNA (n = 4); (3) 300 μg mRNA administered intramuscularly (IM) (n = 5); (4) 300 μg VapA IM (positive controls; n = 6); or (5) nebulized water (negative controls; n = 6). Serum, BALF, and PBMCs were collected at ages 3, 22, and 35 days and tested for relative anti-VapA IgG 1 , IgG 4/7 , and IgA activities using ELISA and cell-mediated immunity by ELISpot. RESULTS As formulated, nebulized mRNA was not immunogenic. However, a significant increase in anti-VapA IgG 4/7 activity ( P < .05) was noted exclusively in foals immunized IM with VapA mRNA by age 35 days. The proportion of foals with anti-VapA IgG 1 activity > 30% of positive control differed significantly ( P = .0441) between negative controls (50%; 3/6), IM mRNA foals (100%; 5/5), and IM VapA (100%; 6/6) groups. Natural exposure to virulent R equi was immunogenic in some negative control foals. CLINICAL RELEVANCE Further evaluation of the immunogenicity and efficacy of IM mRNA encoding VapA in foals is warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rhodococcus equiActinomycetales InfectionsHorse DiseasesAnimalsHorsesAnimals, NewbornImmunity, HumoralmRNA VaccinesBacterial ProteinsLeukocytes, MononuclearImmunoglobulin GRNA, MessengerVirulence Factors

Stichwörter der Autor:innen

Rhodococcus equifoalimmunitymRNAvaccine

Substanzen

mRNA VaccinesBacterial ProteinsImmunoglobulin GRNA, MessengerVirulence Factors

Autor:innen und Institutionen

  • Equine Infectious Disease Laboratory, Department of Large Animal Clinical Sciences, School of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, TX.
  • Department of Pediatrics, Division of Tropical Medicine, Baylor College of Medicine, Houston, TX.
  • Texas Children's Hospital Center for Vaccine Development, Houston, TX.
  • Comparative Immunogenetics Laboratory, Department of Veterinary Pathobiology, School of Veterinary Medicine & Biomedical Sciences, Texas A&M University, College Station, TX.
  • Department of Poultry Science, College of Agriculture & Life Sciences, Texas A&M University, College Station, TX.
  • Center for Musculoskeletal Regeneration, Houston Methodist Research Institute, Houston, TX.

ORCID-Profile: Rebecca M Legere, Noah D Cohen

Zitieren

APA

Legere, R. M., Poveda, C., Ott, J. A., Bray, J. M., Villafone, E. G., Silveira, B. P. D., Kahn, S. K., Martin, C. L., Mancino, C., Taraballi, F., Criscitiello, M. F., Berghman, L., Bordin, A. I., Pollet, J., & Cohen, N. D. (2024). Intramuscular but not nebulized administration of a mRNA vaccine against Rhodococcus equi stimulated humoral immune responses in neonatal foals. American Journal of Veterinary Research. https://doi.org/10.2460/ajvr.23.09.0208

Vancouver

Legere RM, Poveda C, Ott JA, Bray JM, Villafone EG, Silveira BPD, et al. Intramuscular but not nebulized administration of a mRNA vaccine against Rhodococcus equi stimulated humoral immune responses in neonatal foals. American Journal of Veterinary Research. 2024. doi:10.2460/ajvr.23.09.0208

BibTeX
@article{Legere2024,
  author = {Legere, Rebecca M and Poveda, Cristina and Ott, Jeannine A and Bray, Jocelyne M and Villafone, Emma G and Silveira, Bibiana Petri da and Kahn, Susanne K and Martin, Cameron L and Mancino, Chiara and Taraballi, Francesca and Criscitiello, Michael F and Berghman, Luc and Bordin, Angela I and Pollet, Jeroen and Cohen, Noah D},
  title = {Intramuscular but not nebulized administration of a mRNA vaccine against Rhodococcus equi stimulated humoral immune responses in neonatal foals},
  journal = {American Journal of Veterinary Research},
  year = {2024},
  doi = {10.2460/ajvr.23.09.0208}
}
Kostenlos starten →